Benitec Biopharma Inc. (BNTC) AI Dilution Summary

Cash was $180,000,000 at 2026-06-30, the last reported balance-sheet date. The active funding channel is an at-the-market program with Leerink Partners LLC, authorised to $75,000,000. Sales under it are dollar-denominated, so the number of shares it can issue rises as the share price falls.